Martin Wilson
CIK: 0001704342
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ROCKET PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Sep 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct75.4K shares at avg. $3.40$256K - Aug 18, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct631 shares at avg. $3.38$2K - Aug 13, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct3.5K shares at avg. $3.38$12K - May 19, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct662 shares at avg. $3.01$2K - May 13, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct3.4K shares at avg. $3.61$12K - Feb 18, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct1.4K shares at avg. $3.34$5K - Feb 13, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct12.3K shares at avg. $3.31$41K - Feb 11, 2026RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)Direct311.8K shares- - Nov 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct1.6K shares at avg. $2.98$5K - Nov 3, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)Direct100K shares- - Sep 8, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)Direct150K shares- - Aug 19, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct588 shares at avg. $3.00$2K - Aug 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct1K shares at avg. $3.06$3K - Aug 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct12.1K shares at avg. $3.02$37K - May 20, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct587 shares at avg. $6.45$4K - May 16, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct946 shares at avg. $6.53$6K - Feb 21, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct3.2K shares at avg. $10.58$34K - Feb 11, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
Award(A)Direct90.4K shares- - Nov 21, 2024RCKT
ROCKET PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $13.05$15K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 75,364 | $3.40 | $256,464 | Direct |
| Aug 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 631 | $3.38 | $2,133 | Direct |
| Aug 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 3,493 | $3.38 | $11,810 | Direct |
| May 19, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 662 | $3.01 | $1,995 | Direct |
| May 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 3,361 | $3.61 | $12,120 | Direct |
| Feb 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 1,376 | $3.34 | $4,593 | Direct |
| Feb 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 12,253 | $3.31 | $40,582 | Direct |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) | 311,813 | - | $0 | Direct |
| Nov 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 1,646 | $2.98 | $4,910 | Direct |
| Nov 3, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) | 100,000 | - | - | Direct |
| Sep 8, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) | 150,000 | - | - | Direct |
| Aug 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 588 | $3.00 | $1,762 | Direct |
| Aug 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 1,004 | $3.06 | $3,077 | Direct |
| Aug 14, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 12,109 | $3.02 | $36,557 | Direct |
| May 20, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 587 | $6.45 | $3,784 | Direct |
| May 16, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 946 | $6.53 | $6,175 | Direct |
| Feb 21, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 3,222 | $10.58 | $34,089 | Direct |
| Feb 11, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | Award(A) | 90,358 | - | - | Direct |
| Nov 21, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | Sale(S) | 1,175 | $13.05 | $15,338 | Direct |
1-19 of 19 transactions
About Wilson Martin
Wilson Martin (SEC CIK 0001704342) files insider reports with the SEC as General Counsel of ROCKET PHARMACEUTICALS, INC. (RCKT).
Signal8 holds 18 ownership filings by Wilson Martin, all Form 4s, filed between Nov 25, 2024 and Sep 15, 2026. Those filings report 19 transactions, from Nov 21, 2024 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wilson Martin's filings is in CRANBURY, NJ.
Recent filings by Wilson Martin
- Sep 11, 2026: Open-market sale of RCKT shares (Form 4, code S).
- Aug 18, 2026: Open-market sale of RCKT shares (Form 4, code S).
- Aug 13, 2026: Open-market sale of RCKT shares (Form 4, code S).
- May 19, 2026: Open-market sale of RCKT shares (Form 4, code S).
- May 13, 2026: Open-market sale of RCKT shares (Form 4, code S).
Other insiders filing for ROCKET PHARMACEUTICALS, INC. (RCKT)
- Shah Gaurav, CEO
- Stevens Christopher James, Chief Operating Officer
- Chaudhuri Sarbani
- SOUTHWELL DAVID P, Director
- Manhede Joseph, Principal Accounting Officer
- WONG RODERICK, Director